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Abstract
Shiga-toxin-producing Escherichia coli (STEC) infection is an important global cause of foodborne disease. To date however, 
genomics-based studies of STEC have been predominately focused upon STEC collected in the Northern Hemisphere. Here, we 
demonstrate the population structure of 485 STEC isolates in Australia, and show that several clonal groups (CGs) common 
to Australia were infrequently detected in a representative selection of contemporary STEC genomes from around the globe. 
Further, phylogenetic analysis demonstrated that lineage II of the global O157:H7 STEC was most prevalent in Australia, and 
was characterized by a frameshift mutation in flgF, resulting in the H-non-motile phenotype. Strong concordance between in 
silico and phenotypic serotyping was observed, along with concordance between in silico and conventional detection of stx 
genes. These data represent the most comprehensive STEC analysis from the Southern Hemisphere, and provide a framework 
for future national genomics-based surveillance of STEC in Australia.
DATA SummARy
1. All sequence data have been deposited in GenBank; acces-
sion number: BioProject PRJNA319594.
InTRoDuCTIon
Shiga-toxin-producing Escherichia coli (STEC) infection 
is an important cause of foodborne disease, with an esti-
mated 2.48 million cases globally in 2010 [1]. Symptoms 
range from mild gastroenteritis to severe bloody diar-
rhoea [2], and approximately 3–6 % of cases may develop 
haemolytic uremic syndrome (HUS) [3, 4]. Many countries 
have reported STEC outbreaks as a result of ingestion of 
contaminated food or water, and direct or indirect contact 
with human or animal carriers [5–7]. Increasing globaliza-
tion of the food manufacturing and supply chain means that 
STEC outbreaks have the potential to cross international 
borders, illustrated by the large multi-national 2011 Euro-
pean Shiga-toxigenic enteroaggregative E. coli O104:H4 
outbreak associated with contaminated fenugreek sprout 
seeds [8, 9].
Over the past 8 years, whole genome sequencing (WGS) 
has been increasingly used for public health surveillance 
and outbreak investigations, particularly for foodborne 
pathogens [10]. Recent work from the UK has demon-
strated the feasibility of WGS-based national surveillance 
of STEC, and highlighted the ability of WGS to detect 
clusters of STEC cases that were not identified by conven-
tional epidemiological and laboratory-based investigations 
[5, 10, 11]. Moreover, additional work has demonstrated 
strong concordance between conventional STEC serotyping 
for the lipopolysaccharide (LPS) O-antigen and flagellar 
H-antigen, and in silico-derived serotyping, further adding 
to the utility of WGS-based approaches to STEC analysis in 
a public health microbiology setting [11–14].
Like other countries, the main reservoirs of STEC in Australia 
are healthy ruminants, particularly cattle [15]. In 2016, there 
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were 341 notified cases of STEC infection in Australia [16], 
and a previous study suggested that STEC infections cost the 
Australian economy approximately $2.6 million annually 
[17]. Although most cases of STEC infection in Australia 
are considered sporadic, major STEC outbreaks can occur, 
with the largest reported outbreak of serogroup O157 STEC 
in Australia occurring amongst 57 patients in Queensland 
in 2013, associated with exposure to an animal nursery at 
an agricultural show [18]. However, at present in Australia, 
there is no national laboratory-based surveillance of STEC 
infections, resulting in a major knowledge gap in our under-
standing of STEC epidemiology, hampering prevention and 
control efforts. In Australia, epidemiological approaches 
for STEC surveillance have been confined to conventional 
serotyping, providing limited ability to differentiate sporadic 
infections from potential point-source outbreaks [10]. 
Accordingly, there is a pressing need for high-resolution 
characterization of STEC in Australia.
Here, we used WGS to determine the population structure 
of Australian STEC isolates from a spatially and tempo-
rally diverse national collection. To better inform genomic 
surveillance of STEC, we aimed to identify the major lineages 
responsible for STEC infections in Australia and to compare 
the utility and feasibility of in silico typing and virulence gene 
detection with conventional typing approaches. Our data 
represent the most comprehensive STEC dataset to date from 
the Southern Hemisphere and provide a valuable resource for 
future surveillance studies of STEC both within Australia and 
internationally.
mETHoDS
Data sources, sampling strategy and 
microbiological testing
In Australia, STEC is a notifiable disease, and diagnostic labo-
ratories are requested to forward STEC isolates to a reference 
laboratory for further characterization. The Microbiological 
Diagnostic Unit Public Health Laboratory (MDU PHL) is the 
public health reference laboratory for the State of Victoria in 
Australia and is also the national reference laboratory for epide-
miological typing of human-associated STEC in Australia. Since 
1999, STEC isolates in Australia have been referred to MDU PHL 
for serotyping and detection of Shiga toxin(s).
A total of 435 human clinical STEC isolates received at 
MDU PHL between 1 January 2007 and 31 December 2016 
underwent WGS and were included in this study. Additional 
contextual STEC genomes were included, specifically 14 
animal STEC isolates received between 2009 and 2013 from 
bovine or ovine sources, and 36 historical human O157 STEC 
isolates received from 1993 to 2006 (Supplementary Dataset 
1, available in the online version of this article). The genomes 
were quality-controlled (mean depth of coverage over 50×; 
mean quality score Q30; assembled genome size after filtering 
for contigs <500 bp, and genome assembly sizes between 4 
800 000 to 5 800 000 bp) and screened in silico for the pres-
ence of stx genes (see below). In total, 485 STEC isolates were 
included from Australia.
To provide geographical context and enable comparative analysis 
with STEC in circulation globally, publicly available isolates 
were included in phylogenetic analysis. In total, 17 repre-
sentative O157 STEC were included, representing previously 
reported major lineages of O157 STEC and major clades from 
the Manning typing scheme [19, 20]. Further, contemporary 
representatives of other highly prevalent global serogroups [21] 
circulating globally (O103, O111, O121, O145 and O26) were 
included, by screening the 500 most recently added isolates to the 
GenomeTrakr database at the National Center for Biotechnology 
Information (NCBI) ( www. ncbi. nlm. nih. gov/ bioproject/? term= 
PRJNA319594). Sequences with an SRA accession number were 
downloaded (access date 6 January 2017), quality-controlled as 
described above and then screened in silico for the presence of 
stx genes (see below). A random selection of ten genomes was 
included from each serogroup. This resulted in an additional 56 
genomes (only six O145 were identified), with three from the 
UK and 53 from the USA.
Identification and epidemiological typing of the 485 Australian 
STEC isolates included in this study was performed at MDU 
PHL. Phenotypic characterization of O- and H-surface 
antigens was performed using agglutination reactions with 
rabbit antisera, as previously described [12, 22]. Isolates were 
determined as STEC by PCR screening for the stx1 and stx2 
genes using previously described methods [23]. Details of all 
isolates are given in Supplementary Dataset 1.
Whole genome sequencing
DNA extraction and WGS was performed at MDU PHL. 
Sequence libraries were prepared using NexteraXT and 
sequenced on the NextSeq500 (Illumina NextSeq with 150 
bp paired-end reads or MiSeq with 300 bp paired-end reads). 
Reads are available on the NCBI Sequence Read Archive 
(BioProject PRJNA319594).
In silico antimicrobial resistance gene detection and 
multilocus sequence typing
Genome assemblies were constructed using SPAdes (v3.12) 
using the ‘careful’ parameter and kmers of 21, 33, 55, 77 
ImPACT STATEmEnT
The emergence and spread of Shiga-toxin-producing 
Escherichia coli (STEC) has been well described in Europe 
and North America. However, comparatively little is 
known about the circulation of STEC in the Southern 
Hemisphere. Here, in the largest STEC analysis to date 
from the Southern Hemisphere, we describe the major 
lineages of STEC in Australia, and further demonstrate 
the public health utility of genomic data for the char-
acterization and surveillance of STEC. Our data provide 
a valuable framework for ongoing national genomics-
based surveillance of this important public health path-
ogen.
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[24]. Sequence types (STs) were determined with the 
programme ‘mlst’ (https:// github. com/ tseemann/ mlst) 
using the Achtman database [25]. The genome assemblies 
of all isolates were also screened for acquired antimicrobial 
resistance (AMR) determinants in the NCBI resistance 
database using the programme ‘ABRicate’ (https:// github. 
com/ tseemann/ abricate abricate) with a minimum nucleo-
tide identity of 90 % and minimum coverage of 90 %. The 
results were transformed into a binary dataset in R (version 
3.4.0), summarized by clinical drug class and plotted with 
ggplot2 (v2.3.0) [26]. Known quinolone resistance mutations 
(gyrA 83 and 87; parC 80 and 84) were identified as non-
synonymous single nucleotide polymorphisms (SNPs) in 
these quinolone-resistance determining regions [27].
In silico detection of serotype and stx genes
In silico O:H serotyping was performed using the EcOH 
database with SRST2 [28], with the minimum read depth 
set to 1. The Simpson’s Index of Diversity was calculated 
for both the O-group and the H-types within the most 
common clonal groups (CGs) using the ‘vegan’ package in 
R (version 3.4.0) [29]. The stx genes were initially identified 
with SRST2 [28], using the same stx genes as Ashton et al. to 
construct the toxin database [30]. Mutations in the stx genes 
in CG504 isolates were investigated using ARIBA [31]. In 
silico data were compared to data produced from conven-
tional typing methods (see above). O-groups that fell within 
previously described O-antigen clusters [32] were classified 
as concordant. Both A and B subunits had to be detected 
from the in silico screen for the Stx1 or Stx2 complex to be 
classified as genotypically present.
Phylogenomic analysis of core genome
WGS reads were trimmed to clip Illumina Nextera adapters 
and low-quality read data (Phred score <10) using Trim-
momatic [33]. The 558 genomes were mapped to the refer-
ence chromosome genome O157:H7 Sakai (NCBI accession 
number: NC_002695.2) using Snippy (v4.3.4)/BWA MEM 
0.7.15-r1140 [34] (https:// github. com/ tseemann/ snippy). 
SNPs were called using Snippy (v4.3.4)/Freebayes requiring a 
minimum read coverage of 10× at variant sites and minimum 
proportion of variant evidence of 0.90 [35]. Phage regions 
were identified in the Sakai reference chromosome using 
PHASTER [36] and SNPs in these regions were masked. A 
core genome alignment of 235 746 informative SNPs was 
produced using snippy-core (v4.3.4) and used as input for 
IQ-TREE (v1.6.5) [37] with the GTR+G4 model, constant 
sites (1 590 440, 1 477 994, 1 550 215 and 1 549 891), ultrafast 
bootstrapping with 1000 replicates, the SH-aLRT parameter 
with 1000 bootstrap replicates [38] to infer the phylogenetic 
structure.
Lineages were defined from this tree using RAMI [39] with a 
patristic distance threshold of 0.0004. This threshold defined 
two well-characterized lineages within E. coli, specifically 
ST11 (associated with O157:H7), and the precursor to this 
lineage, ST335 (associated with O55:H7). CGs were identified 
by the most common ST within the lineage.
Subset analysis of CG11
In order to further define CG11, the core genome alignment 
for CG11 was extracted using snippy-core (https:// github. 
com/ tseemann/ snippy). The resulting SNPs were used to 
generate a pseudo-whole genome alignment, in which 
recombination was detected using Gubbins [40], leaving a 
recombination-filtered core genome alignment of 10 377 
SNPs. A recombination-filtered phylogeny of CG11 was first 
inferred using IQ-TREE (v1.6.5) as described above. We then 
investigated the temporal signal within CG11 using Tempest 
(v1.5) [41] by conducting a regression of the root-to-tip 
branch distances of the CG11 ML phylogeny. The resulting 
data was visualized in R (version 3.4.0) (Fig. S1a). Pairwise 
SNP distances between isolates were calculated using the 
R package harrietR (v0.2.3) (https:// github. com/ andersgs/ 
harrietr). SNP distances between any isolates were filtered 
to ≤10 using tidyverse (v1.2.1) (https:// CRAN. R- project. 
org/ package= tidyverse), before being visualized against the 
phylogeny using ggtree [42]. Putative clusters were defined 
as groups with two or more isolates with ≤10 pairwise SNPs.
The recombination-filtered SNP alignment was used in beast 
v2.5.1 to estimate a Bayesian phylogeny with divergence dates 
[43]. The model parameters were GTR+Γ substitution model 
with alternative clock; strict and relaxed lognormal clock, and 
alternative population priors; constant coalescent population 
and constant exponential population tested. The highest 
supported model was the relaxed lognormal clock under a 
constant population size and ten independent beast runs of 
100 million states. These independent runs were combined 
using LogCombiner v2.5.1, with 20 % burn-in removed and 
all ESS scores were above 200 and parameter estimates were 
calculated using Tracer v1.6 [43]. A maximum clade cred-
ibility tree was constructed using TreeAnnotator v2.5.1. To 
test the robustness of the molecular clock signal, five further 
beast runs with randomized tip dates were generated using 
the highest supported model with 75 million states and 
burn-in of 20 million [44] (Fig. S1b). The final maximum 
clade credibility tree was visualized in R using ggtree [42].
Clade typing using the Manning scheme [20] was performed 
within the CG11 group by identifying nine definitive SNPs, 
eight from Yokoyama et al. [45] and the inclusion of addi-
tional SNPs [46] from the VCF files produced from mapping 
analysis produced by Snippy. Primer sequences were used to 
confirm the correct loci for the eight SNPs in artemis [47], and 
the reference base confirmed in the O157:H7 Sakai (NCBI 
accession number: NC_002695.2). Importantly, we observed 
that some of the loci or bases specified did not match the 
reference Sakai genome; the nine SNPs used are described in 
Supplementary Dataset 2.
ISmapper [48] was run with default parameters to screen 
all read sets for insertion sites of the transposase IS1203v 
(accession AB017524.1) relative to the reference chromosome 
O157:H7 Sakai (NCBI accession number: NC_002695.2). 
The binary data was processed in R using tidyverse (v1.2.1) 
(https:// CRAN. R- project. org/ package= tidyverse). The inser-
tion of a cytosine base in position 125 in flgF associated with 
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a H-non-motile phenotype [49] in Australian CG11 isolates 
from human cases between 2007–2016 was investigated from 
the Snippy output by manually identifying insertions at this 
site.
Subtyping of stx genes in CG11
A combination of mapping and assembly-based approaches 
were used to infer stx subtypes [30] using results from SRST2 
and ABRicate, which report calls to the stx A and B subunit 
genes. In isolates with hits to both stx2A and stx2C alleles, the 
depth of reads mapping to the stx2A subunit from SRST2 was 
compared to the average depth. Previously subtyped isolates 
were included in our stx subtyping in order to validate our 
approach [19].
national surveillance data for STEC
The National Notifiable Disease Surveillance System 
(NNDSS) was established in Australia in 1990 and coordi-
nates the surveillance of >50 communicable disease or disease 
groups. Notifications of diseases, such as STEC, are made to 
the relevant State or Territory health authority, de-identified 
and then supplied to the Australian Government Department 
of Health. The NNDSS data for STEC for raw numbers and 
rates per 100 000 by State/Territory and Year were accessed 
on 1 March 2018 at . The raw counts and rates per 100 000 for 
the period of 2007 to 2016 inclusive were plotted in R using 
ggplot2 [26].
RESuLTS AnD DISCuSSIon
The genomic epidemiology of STEC in Australia
To investigate the population structure of STEC in Australia, 
we constructed a core genome phylogeny of all 558 STEC 
genomes included in this study. A total of 52 lineages 
were identified (based on patristic distance generated 
with RAMI [39]), of which there were eight CGs with ten 
or more isolates (Fig.  1). These eight CGs accounted for 
85.1 % (475/558) of the STEC genomes included in this 
study, with the Sakai O157:H7 reference genome also 
falling within the largest CG, namely CG11. The CG11 
lineage, associated with the O157:H7 serotype, accounted for 
55.7 % (311/558) of all isolates (Fig. 1). The most common 
serogroups after O157 in this study were O26 (10.8 %; 59/558 
isolates), O111 (7.3 %; 41/558), O128 (3.8 %, 21/558), O-Gp8 
(the O117 allele) (1.9 %; 11/558) and O91 (1.8 %; 10/558), 
with the remaining isolates characterized by over 40 different 
O-antigens (including 11 for which no in silico serotype was 
determined) (Supplementary Dataset 1), highlighting the 
diversity of STEC lineages in Australia.
We compared the occurrence of the O157 and several other 
highly prevalent global serogroups [21] in Australia relative 
to international isolates, identifying geographic differences 
between the observed serotypes in the eight CGs. For example, 
we identified 11 isolates with the O103:H2 serotype (associ-
ated with the CG17 lineage), although only one was from 
Australia (Supplementary Dataset 1). We also identified a rare 
serotype combination of O103:H25, previously reported as 
the causative agent of HUS in Norway in 2006, associated with 
cured mutton sausages [50]. Similar patterns of low repre-
sentation of Australian STEC in serogroups O121 and O145 
was observed. These two serogroups were associated with two 
STEC lineages, namely CG655 (n=11) with O121:H19, and 
CG32 (n=7) with O145:H-. Both lineages were comprised of 
publicly available isolates from the USA, with the exception 
of a single Australian isolate in each lineage. Greater numbers 
of Australian STEC fell within the two highly prevalent global 
serogroups, O26 and O111. The O26:H11 serotype, associ-
ated with CG21, comprised both Australian and international 
genomes, and the O111 serogroup was identified in serotypes 
O111:H8, O111:H- (no H-type determined in silico) and 
O111:H11.
The prevalence of acquired AMR determinants was 
uncommon in the main STEC CGs detected in the dataset 
(Fig.  2, Supplementary Dataset 3), except for the CG504 
lineage, in which multiple AMR determinants were detected, 
with most isolates in CG504 having acquired AMR genes to 
between two and five classes of antimicrobials (Figs 2 and 
S2). No non-synonymous point mutations were detected 
in parC, with only one point mutation in gyrA (Asp87Tyr) 
detected in a O157 historical isolate. Interestingly, in nine 
isolates a complex mutation in gyrA, specifically a deletion 
at base 248 and an insertion at base 252, resulting in a non-
synonymous base change in gyrA (Ser83Leu) was detected. 
Six of these isolates were part of CG504 (Fig. S2). Of note, 
all isolates within CG504 either had a frameshift mutation 
(F111fs) or non-synonymous point mutation (L171S) in the 
stx1 A subunit; future work should assess the impact of these 
mutations on Stx1 expression and functionality.
The o157:H7 STEC lineage II is successfully 
established in Australia
To investigate the emergence of O157:H7, we used 10 377 
SNPs identified in the core genome of the CG11 lineage to 
construct a timed phylogeny (Fig. 3). Preliminary analysis 
revealed temporal structure within this lineage (Fig. S1a). The 
substitution rate (the number of substitutions per site per year) 
was 3.4E-07 (Fig. S1b), corresponding to previous estimates 
within E. coli pathotypes [19, 51]. Further, the molecular clock 
signal was robust as no overlap of highest posterior density 
(HPD) for the substitution rate was observed for the beast 
runs with randomized tip dates (Fig. S1b).
Our data suggest that the most recent common ancestor 
(MRCA) of all the O157 STEC isolates in our study likely 
occurred around 1800 (HPD of 1743–1852), consistent with 
previous findings [19]. We observed geographic variation 
within the O157 phylogeny, reflected in the distribution 
of the Australian isolates in the Manning clades (Manning 
classification; Supplementary Datasets 2 and 4). Notably, 
only a small proportion of the Australian STEC fell within 
clade 3, clade 4/5 or clade 6 (all associated with lineage I [19] 
(Fig.  3). The majority of the Australian isolates (95.1 %, 
270/284) in the CG11-specific phylogeny typed as clade 7. 
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Fig. 1. Overview of STEC population structure in Australia. The inferred core phylogeny of 558 STEC genomes produced from 235 746 
informative SNPs. The reference genome was O157:H7 Sakai (NCBI accession number: NC_002695.2). Identified CGs are delineated by 
the most common ST in the CG. The eight major CGs are identified by different colours.
Nearly all human Australian isolates clustered with the lineage 
II reference isolates [19], as did all ten O157 animal isolates 
from Australia. Of note, the MRCA for the dominant clade 
7 sublineage within Australian 0157 STEC was 1855 (HPD 
1830–1877), possibly associated with migration of humans 
and animal from Europe to Australia. Importantly, the inser-
tion of a cytosine base in position 125 in flgF (associated 
with a non-motile flagellar [49]) was only found in isolates 
within this sublineage, and was significantly associated with 
the H-non-motile phenotype (Supplementary Dataset 4). 
This non-motile phenotype is regarded as a epidemiological 
marker for Australian O157 STEC. Within Australian 0157 
STEC, the most common stx subtypes were stx1a and stx2c 
(Fig. 3, Supplementary Dataset 4), with interruptions in the 
stx2c A subunit detected in isolates associated with a 2013 
outbreak [18]. This genotype has previously been shown 
to be due to an interruption of the gene by an IS element 
IS1203v [18], and the phylogenetic structure suggests that the 
outbreak strains emerged locally from the established lineage 
II (Fig. 3).
Collectively, our data demonstrate that O157 STEC in 
Australia is distinct from that in the Northern Hemisphere, 
based upon our comprehensive sampling of Australian 
STEC over a 10-year period (Fig. S3). Our data support the 
hypothesis that while there have been multiple introductions 
of O157 sub-lineages to Australia, the dominant lineage II, 
associated with the H-non-motile phenotype, has been the 
most successful in the Australian environment.
utility of genomics-based approaches in public 
health microbiology
Similar to previous studies [10–12], we observed high 
concordance between O- and H-antigen phenotypic 
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Fig. 2. Summary of the features of the eight most common STEC CGs in this study. Data indicates the source (geography or animal or 
historic Australian) of the genomes included in the CGs. The N (Aus) indicates the number of isolates from humans between 2007–2016. 
The ‘O-group’ indicates the distinct O-antigen genes detected in the isolates. The ‘H-type’ indicates the distinct H-antigen genes detected 
in the isolates. Where no O-group or H-type was detected in silico, this is given by O- and H-, respectively. ‘AMR profiles’ indicates the 
proportion of AMR determinants acquired by horizontal gene transfer grouped by drug class detected in the STEC isolates.
serotyping and in silico serotyping. In silico serotyping 
detected an O-group in 98.4 % (428/435) of isolates, with 
96.4 % concordance (370/384 isolates) between phenotype 
and genotype (Table S1). In silico H-types were detected 
in 96.1 % (418/435) isolates, and of the 135 isolates with a 
H-antigen phenotype, concordance was 98.5 % (133/135) 
(Table S1). Discordance between phenotype and genotype 
may be due to several factors, including (i) detection of novel 
antigens (e.g. two isolates with O28 phenotypes characterized 
with in silico OgN9) and (ii) laboratory errors with pheno-
typing (e.g. transcription or processing errors). Interestingly, 
of the 300 Hnt isolates in this study, 228 (76 %) were from 
CG11 and while the fliC gene was intact, point mutations in 
flgF were detected (discussed above) (Table S2, Supplemen-
tary Dataset 4). The other Hnt isolates were detected in CG33 
(n=10) and CG294 (n=27), with the remaining 35 distributed 
over 16 different lineages. Future work should explore the 
presence of additional mutations in the flagellar operon, and 
assess the presence of these in the Australian setting.
In addition to in silico serotyping, we undertook in silico 
determination of the A and B subunit of the stx genes, stx1 
and stx2 respectively, and compared with conventional PCR 
detection (Table S3). Of the 435 isolates, 78 had stx1 detected 
by PCR, 67 had stx2 and 290 had both stx1 and stx2 detected 
(Supplementary Datasets 1 and 4). Concordance for stx1 
detection (based on in silico detection of both subunits) was 
97.8 % (360/368), and for stx2 detection was lower, at 75.1 % 
(268/357). However, on further investigation, in eight stx1 
and 31 stx2 ‘discordant’ isolates, both the A and B subunits 
were completely absent (using both mapping and blast 
approaches), suggesting a possible loss of Stx phages during 
long-term storage between the time of PCR detection and 
WGS. In addition, the stx2A subunit gene was incomplete 
in 54 isolates, with three isolates from 2009 and 51 isolates 
from 2013 found to have only 84.27 and 48.33 % coverage 
respectively of this gene. These 54 isolates were detected by 
conventional PCR as the primer sites remained intact, despite 
interruption of the gene. All 54 of these isolates clustered 
in the CG11 lineage (Fig. 3), consistent with a previously 
reported outbreak [18] that described interruption of the 
stx2 A gene by IS1203v (GenBank accession AB017524.1). 
We used ISmapper [48] and Bandage [52] to investigate the 
interruption of the stx2 A subunit gene with this IS element 
in all isolates, but given the fragmented nature of the genomes 
and the integration of the IS element into another mobile 
element, we were unable to resolve the interruption of the 
gene. However, we hypothesize that all of these isolates would 
have a non-functional form of the Stx2 toxin, as previously 
suggested [18].
To investigate the potential of genomics-based approaches in 
identifying putative STEC clusters, we utilized the pairwise 
SNP distances determined from the recombination-filtered 
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Fig. 3. Phylogeny of CG11 suggests emergence of local Australian STEC. (a) Maximum clade credibility phylogeny of 311 isolates 
belonging to the CG11 lineage, including the reference Sakai genome. Tips are coloured by Manning clade membership [20] determined 
in silico. The scale is in years and nodes of posterior support ≥95 are indicated in the phylogeny by black circles at the node. Isolates 
from the 2013 STEC outbreak associated with cattle are indicated to the right of the phylogeny [18]. (b) Geographic location of strain 
collection site (AUS: Australia, UK: United Kingdom and USA: United States of America). (c) The presence of stx subtypes is shown to the 
right of the phylogeny. (d) H-type phenotype data (where available) is shown, together with detection of an insertion of a cytosine base 
in position 125 in flgF associated with a non-motile flagellar phenotype. (e) Isolates that were ten pairwise SNPs from another isolate 
are shown in black.
CG11 SNP alignment. As an epidemiologically validated 
‘control’ dataset, we used the CG11 isolates from a known 
outbreak in Queensland, Australia in 2013 [18]. Having estab-
lished that a single linkage SNP threshold of ≤10 SNPs was able 
to identify the QLD isolates in the 2013 outbreak, we applied 
this threshold to other isolates within the CG11 lineage. A 
total of 18 putative clusters were identified, comprising two 
or more non-duplicate isolates with a maximum distance of 
ten SNPs (Supplementary Dataset 5). We identified six addi-
tional clusters spanning multiple Australian States, including 
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an interstate cluster from 2009 from a previously described 
outbreak [53]. While we did not have detailed epidemio-
logical data to validate these clusters, our study provides a 
genomic framework for future epidemiological investigations. 
The detection of known outbreaks, and putative outbreaks 
spanning jurisdictional boundaries demonstrate the capacity 
of such an approach to identify geographically dispersed 
outbreaks of STEC.
Finally, this study also highlights the potential public health 
impact of culture independent diagnostic testing (CIDT) on 
genomic surveillance of pathogens. Overall, only 31.3 % of 
STEC notifications across the study period were associated 
with a culture (Fig. S3); this proportion dropped further in 
2017 due to the increased use of CIDT in one jurisdiction 
(Fig. S3). Given the potential for STEC to cause large 
outbreaks, it is critical that concerted efforts are made to 
ensure continuation of culture-based surveillance.
Conclusions
Here, we provide insights into the population structure 
and emergence of STEC in Australia. We demonstrate that 
the distribution of STEC in Australia differs from STEC in 
the Northern hemisphere, specifically in that not all of the 
prevalent global serotypes were highly represented in the 
Australian STEC collection. Instead, we observed that STEC 
in Australia comprised a diverse range of lineages, with the 
most common lineage of O157 STEC (associated with a non-
motile phenotype) emerging in the mid-nineteenth century. 
We further corroborate the public health utility of genomic 
data for the characterization and surveillance of STEC, 
and describe a valuable framework for ongoing national 
genomics-based surveillance of this important public health 
pathogen.
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